董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Matthew E. Monaghan | 男 | Chairman, President and Chief Executive Officer | 52 | 359.63万美元 | 未持股 | 2020-03-09 |
| Marc M. Gibeley | 男 | Director | 60 | 4.99万美元 | 未持股 | 2020-03-09 |
| Clifford D. Nastas | 男 | Director | 62 | 12.67万美元 | 未持股 | 2020-03-09 |
| Susan H. Alexander | -- | Director | -- | 未披露 | 未持股 | 2020-03-09 |
| Julie A. Beck | -- | Director | -- | 未披露 | 未持股 | 2020-03-09 |
| Petra Danielsohn Weil | -- | Director | -- | 未披露 | 未持股 | 2020-03-09 |
| Diana S. Ferguson | -- | Director | -- | 未披露 | 未持股 | 2020-03-09 |
| C. Martin Harris | 男 | Director | 68 | 16.87万美元 | 未持股 | 2020-03-09 |
| Baiju R. Shah | 男 | Director | 53 | 16.24万美元 | 未持股 | 2020-03-09 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Matthew E. Monaghan | 男 | Chairman, President and Chief Executive Officer | 52 | 359.63万美元 | 未持股 | 2020-03-09 |
| Kathleen P. Leneghan | 女 | Senior Vice President and Chief Financial Officer | 56 | 未披露 | 未持股 | 2020-03-09 |
| Ralf A. Ledda | 男 | Senior Vice President and General Manager, Europe, Middle East & Africa | 52 | 未披露 | 未持股 | 2020-03-09 |
| Darcie L. Karol | 女 | Senior Vice President, Human Resources | 53 | 未披露 | 未持股 | 2020-03-09 |
| Anthony C. LaPlaca | 男 | Senior Vice President, General Counsel and Secretary | 61 | 102.32万美元 | 未持股 | 2020-03-09 |
董事简历
中英对照 | 中文 | 英文- Matthew E. Monaghan
-
Matthew E. Monaghan，他于2015年4月1日被正式任命为公司的总裁兼首席执行官。2014年1月以来，他曾一直担任Zimmer Holdings, Inc.（NYSE：ZMH）的高级副总裁，负责全球高完整性保护系统和复原研究。Zimmer Holdings公司设计、开发、制造和营销整形重建、脊椎和创伤设备、牙科植入物，以及相关外科产品。他曾领导公司的全球高完整性保护系统业务和大型联合复原研究，在那里他负责部门的新产品开发、工程、市场营销、临床研究、质量、法规事务、共享销售结果和供应链职能。从2009年12月到2014年1月，他担任Zimmer公司的副总裁兼总经理，负责全球高完整性保护系统业务。2009年加入Zimmer公司之前，他曾任职两个领先私人股本公司（Texas Pacific Group （TPG） 、Cerberus Capital Management）8年，担任运营执行官，在那里他曾领导投资公司的收购和业务改进（包括Baxter Healthcare的全球医疗设备业务分离，以及美国个人保险业务的显著改善，并运营一个Newell-Rubbermaid公司拆分出来的耐用消费品业务）。任职Cerberus Capital公司期间，他曾担任Global Home Products公司（Cerberus公司的一个耐用消费品业务）的首席运营官（从2004年4月到2005年11月）。Global Home Products公司于2006年4月根据美国破产法第11章提出自愿重组的请愿书。Global Home Products公司于2008年2月摆脱破产。13年以上，他曾担任General Electric （NYSE：GE）的多种职务（2003年之前）。
Matthew E. Monaghan,President and Chief Executive Officer at Invacare Corporation NYSE:IVC, a medical device manufacturer for the home and long-term healthcare markets since 2015.Senior Vice President and General Manager, Global Hips and Reconstructive Research for Zimmer Biomet Holdings, Inc. formerly known as Zimmer Holdings, Inc. (NYSE:ZBH), a global company that designs, develops, manufactures and markets orthopedic reconstructive, spinal and trauma devices, dental implants, and related surgical products (2014-2015).Operating Executive for Texas Pacific Group (2006 to 2009).Cerberus Capital Management (2003 to 2005).13 years in the aerospace, medical and other industrial businesses of General Electric. - Matthew E. Monaghan，他于2015年4月1日被正式任命为公司的总裁兼首席执行官。2014年1月以来，他曾一直担任Zimmer Holdings, Inc.（NYSE：ZMH）的高级副总裁，负责全球高完整性保护系统和复原研究。Zimmer Holdings公司设计、开发、制造和营销整形重建、脊椎和创伤设备、牙科植入物，以及相关外科产品。他曾领导公司的全球高完整性保护系统业务和大型联合复原研究，在那里他负责部门的新产品开发、工程、市场营销、临床研究、质量、法规事务、共享销售结果和供应链职能。从2009年12月到2014年1月，他担任Zimmer公司的副总裁兼总经理，负责全球高完整性保护系统业务。2009年加入Zimmer公司之前，他曾任职两个领先私人股本公司（Texas Pacific Group （TPG） 、Cerberus Capital Management）8年，担任运营执行官，在那里他曾领导投资公司的收购和业务改进（包括Baxter Healthcare的全球医疗设备业务分离，以及美国个人保险业务的显著改善，并运营一个Newell-Rubbermaid公司拆分出来的耐用消费品业务）。任职Cerberus Capital公司期间，他曾担任Global Home Products公司（Cerberus公司的一个耐用消费品业务）的首席运营官（从2004年4月到2005年11月）。Global Home Products公司于2006年4月根据美国破产法第11章提出自愿重组的请愿书。Global Home Products公司于2008年2月摆脱破产。13年以上，他曾担任General Electric （NYSE：GE）的多种职务（2003年之前）。
- Matthew E. Monaghan,President and Chief Executive Officer at Invacare Corporation NYSE:IVC, a medical device manufacturer for the home and long-term healthcare markets since 2015.Senior Vice President and General Manager, Global Hips and Reconstructive Research for Zimmer Biomet Holdings, Inc. formerly known as Zimmer Holdings, Inc. (NYSE:ZBH), a global company that designs, develops, manufactures and markets orthopedic reconstructive, spinal and trauma devices, dental implants, and related surgical products (2014-2015).Operating Executive for Texas Pacific Group (2006 to 2009).Cerberus Capital Management (2003 to 2005).13 years in the aerospace, medical and other industrial businesses of General Electric.
- Marc M. Gibeley
-
Marc M. Gibeley，2015年11月20日被任命为董事。他是Roche Holding AG（SIX： RO，总部位于瑞士巴塞尔）在北美地区的糖尿病护理主管，Roche是一个以研究为中心的制药和医疗保健诊断公司。在Roche，他负责其在美国和加拿大糖尿病护理的各个方面，包括销售、营销、金融和客户支持。2008年至2011年，他担任了WaveRx（风投支持的糖尿病神经病变医疗器械公司）的总裁兼首席执行官。在加入WaveRx之前，他供职于数个定制包装产品公司，包括Procter & Gamble （纽交所： PG）， Eastman Kodak （纽交所： KODK）和Kraft Foods （纳斯达克： KHC）. 他于1987年毕业于the United States Naval Academy，获得了the University of Chicago的工商管理硕士学位。
Marc M. Gibeley was appointed by the Board as a director on November 20 2015. Mr. Gibeley serves as Head of Diabetes Care North America for Roche Holding AG SIX: RO. Headquartered in Basel, Switzerland, Roche is a research-focused pharmaceutical and healthcare diagnostic company. At Roche, Mr. Gibeley is responsible for all aspects of Roche's diabetes care business in the United States and Canada, including sales, marketing, finance and customer support. From 2008 through 2011 Mr. Gibeley served as the President and Chief Executive Officer of WaveRx, a venture-backed diabetes neuropathy medical device company. Prior to joining WaveRx, Mr. Gibeley worked for several consumer packaged goods companies, including Procter & Gamble (NYSE: PG), Eastman Kodak (NYSE: KODK) and Kraft Foods (NASDAQ: KHC). Mr. Gibeley graduated from the United States Naval Academy in 1987 and holds his M.B.A. from the University of Chicago. - Marc M. Gibeley，2015年11月20日被任命为董事。他是Roche Holding AG（SIX： RO，总部位于瑞士巴塞尔）在北美地区的糖尿病护理主管，Roche是一个以研究为中心的制药和医疗保健诊断公司。在Roche，他负责其在美国和加拿大糖尿病护理的各个方面，包括销售、营销、金融和客户支持。2008年至2011年，他担任了WaveRx（风投支持的糖尿病神经病变医疗器械公司）的总裁兼首席执行官。在加入WaveRx之前，他供职于数个定制包装产品公司，包括Procter & Gamble （纽交所： PG）， Eastman Kodak （纽交所： KODK）和Kraft Foods （纳斯达克： KHC）. 他于1987年毕业于the United States Naval Academy，获得了the University of Chicago的工商管理硕士学位。
- Marc M. Gibeley was appointed by the Board as a director on November 20 2015. Mr. Gibeley serves as Head of Diabetes Care North America for Roche Holding AG SIX: RO. Headquartered in Basel, Switzerland, Roche is a research-focused pharmaceutical and healthcare diagnostic company. At Roche, Mr. Gibeley is responsible for all aspects of Roche's diabetes care business in the United States and Canada, including sales, marketing, finance and customer support. From 2008 through 2011 Mr. Gibeley served as the President and Chief Executive Officer of WaveRx, a venture-backed diabetes neuropathy medical device company. Prior to joining WaveRx, Mr. Gibeley worked for several consumer packaged goods companies, including Procter & Gamble (NYSE: PG), Eastman Kodak (NYSE: KODK) and Kraft Foods (NASDAQ: KHC). Mr. Gibeley graduated from the United States Naval Academy in 1987 and holds his M.B.A. from the University of Chicago.
- Clifford D. Nastas
-
Clifford D. Nastas，他一直担任公司的董事（2015年以来）。他于2016年1月被任命为Radiac Abrasives Company（北美传统保税超硬磨料制品的制造商）的首席执行官。2014年以来，他一直担任Dan T. Moore Company, Inc（各种先进材料制造技术企业的控股公司）的董事，并于2016年成为联席主席。2014年以来，他曾担任Shorr Packaging Corporation（ESOP北美包装用品销售公司）的董事。他曾担任Material Sciences Corporation（原为Nasdaq：MASC，位于伊利诺斯州的埃尔克格罗夫，一个公开上市的多元化的工业制造公司，提供高价值金属涂层、声学和轻质复合解决方案）的首席执行官和董事（从2005年到2014年3月公司出售）。从2001年到2005年，他担任Material Sciences公司的多种职务，包括担任总裁兼首席运营官。加入Material Sciences之前，他曾担任多种综合管理销售、制造职务，任职于Honeywell International（原为Allied Signal，NYSE：HON，位于新泽西州莫里斯镇）、Avery Dennison Corporation （NYSE：AVY，位于加州格伦代尔）、Ford Motor Company （NYSE：F，位于密歇根州迪尔伯恩）。从2009年到2010年，他曾是Quixote Corporation （原为NASDAQ：QUIX，一家上市公路和交通安全产品制造商，于2011年2月被收购）的董事和审计委员会成员。
Clifford D. Nastas has been a director of the Company since 2015. In January 2016 Nastas was appointed Chief Executive Officer of Radiac Abrasives Company, a manufacturer of conventional bonded and superabrasives in North America. Since 2014 Mr. Nastas has been a director of Dan T. Moore Company, Inc., a holding company of diverse advanced materials manufacturing and technology businesses, and became co-chairman in 2016. Also since 2014 Mr. Nastas has served as a director of Shorr Packaging Corporation, an ESOP owned company that distributes packaging supplies throughout North America. Mr. Nastas served as Chief Executive Officer and a director of Material Sciences Corporation formerly, Nasdaq: MASC, Elk Grove Village, Illinois, a publicly traded diversified industrial manufacturing company providing high-value coated metal, acoustical and lightweight composite solutions from 2005 until the company was sold in March 2014. From 2001 to 2005 Mr. Nastas served in various capacities at Material Sciences, including as President and Chief Operating Officer. Prior to joining Material Sciences, Mr. Nastas served in various general management, sales, and manufacturing capacities with Honeywell International, formerly Allied Signal (NYSE: HON), Morris Township, New Jersey, Avery Dennison Corporation (NYSE: AVY), Glendale, California, and Ford Motor Company (NYSE: F), Dearborn, Michigan. From 2009 to 2010 Mr. Nastas was a director and member of the audit committee of Quixote Corporation (formerly, NASDAQ: QUIX), a publicly traded manufacturer of highway and transportation safety products, that was acquired in February 2011. - Clifford D. Nastas，他一直担任公司的董事（2015年以来）。他于2016年1月被任命为Radiac Abrasives Company（北美传统保税超硬磨料制品的制造商）的首席执行官。2014年以来，他一直担任Dan T. Moore Company, Inc（各种先进材料制造技术企业的控股公司）的董事，并于2016年成为联席主席。2014年以来，他曾担任Shorr Packaging Corporation（ESOP北美包装用品销售公司）的董事。他曾担任Material Sciences Corporation（原为Nasdaq：MASC，位于伊利诺斯州的埃尔克格罗夫，一个公开上市的多元化的工业制造公司，提供高价值金属涂层、声学和轻质复合解决方案）的首席执行官和董事（从2005年到2014年3月公司出售）。从2001年到2005年，他担任Material Sciences公司的多种职务，包括担任总裁兼首席运营官。加入Material Sciences之前，他曾担任多种综合管理销售、制造职务，任职于Honeywell International（原为Allied Signal，NYSE：HON，位于新泽西州莫里斯镇）、Avery Dennison Corporation （NYSE：AVY，位于加州格伦代尔）、Ford Motor Company （NYSE：F，位于密歇根州迪尔伯恩）。从2009年到2010年，他曾是Quixote Corporation （原为NASDAQ：QUIX，一家上市公路和交通安全产品制造商，于2011年2月被收购）的董事和审计委员会成员。
- Clifford D. Nastas has been a director of the Company since 2015. In January 2016 Nastas was appointed Chief Executive Officer of Radiac Abrasives Company, a manufacturer of conventional bonded and superabrasives in North America. Since 2014 Mr. Nastas has been a director of Dan T. Moore Company, Inc., a holding company of diverse advanced materials manufacturing and technology businesses, and became co-chairman in 2016. Also since 2014 Mr. Nastas has served as a director of Shorr Packaging Corporation, an ESOP owned company that distributes packaging supplies throughout North America. Mr. Nastas served as Chief Executive Officer and a director of Material Sciences Corporation formerly, Nasdaq: MASC, Elk Grove Village, Illinois, a publicly traded diversified industrial manufacturing company providing high-value coated metal, acoustical and lightweight composite solutions from 2005 until the company was sold in March 2014. From 2001 to 2005 Mr. Nastas served in various capacities at Material Sciences, including as President and Chief Operating Officer. Prior to joining Material Sciences, Mr. Nastas served in various general management, sales, and manufacturing capacities with Honeywell International, formerly Allied Signal (NYSE: HON), Morris Township, New Jersey, Avery Dennison Corporation (NYSE: AVY), Glendale, California, and Ford Motor Company (NYSE: F), Dearborn, Michigan. From 2009 to 2010 Mr. Nastas was a director and member of the audit committee of Quixote Corporation (formerly, NASDAQ: QUIX), a publicly traded manufacturer of highway and transportation safety products, that was acquired in February 2011.
- Susan H. Alexander
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Julie A. Beck
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Petra Danielsohn Weil
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Diana S. Ferguson
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- C. Martin Harris
-
C. Martin Harris，医学博士，自2003年以来一直是董事；被任命为Invacare首席董事，在2012年5月17日生效。Harris 博士自1996年以来一直是The Cleveland Clinic Foundation in Cleveland在俄亥俄州，克利夫兰的信息技术部门的首席信息官和主席；The Cleveland Clinic Hospital和General Internal Medicine的克利夫兰诊所的基础部门的医生。此外，自2000年以来他一直担任e-Cleveland Clinic的执行董事，这是e-health临床项目在互联网上提供的一个系列。Harris 博士是HealthStream Inc. NASDAQ, Nashville, Tennessee的董事，该公司为在美国的医疗行业提供基于互联网的培训，信息，和教育的学习和研究解决方案；并且是位于马萨诸塞州，沃尔瑟姆的Thermo Fisher Scientific Inc. （NYSE）（纽约证券交易所）的董事，该公司为研究、制造、分析，发现和诊断提供分析仪器、设备、试剂和耗材，软件和服务。Harris 博士是Sentillion Corporation的董事，一个位于马萨诸塞州安多弗的医疗软件科技公司，在2010年初被卖给微软公司（Microsoft Corporation）。
C. Martin Harris,has served as Vice President of the Health Enterprise and Chief Business Officer of the Dell Medical School at The University of Texas at Austin since 2016. Dr. Harris previously served as Chief Information Officer and Chairman of the Information Technology Division of The Cleveland Clinic Foundation, a non-profit academic medical center, and a Staff Physician for The Cleveland Clinic Hospital and The Cleveland Clinic Foundation Department of General Internal Medicine from 1996 to 2016. Additionally, from 2000 to 2016, he was Executive Director of e-Cleveland Clinic, a series of e-health clinical programs offered over the internet. Prior to joining the Cleveland Clinic, Dr. Harris spent 14 years with the School of Medicine at the University of Pennsylvania. - C. Martin Harris，医学博士，自2003年以来一直是董事；被任命为Invacare首席董事，在2012年5月17日生效。Harris 博士自1996年以来一直是The Cleveland Clinic Foundation in Cleveland在俄亥俄州，克利夫兰的信息技术部门的首席信息官和主席；The Cleveland Clinic Hospital和General Internal Medicine的克利夫兰诊所的基础部门的医生。此外，自2000年以来他一直担任e-Cleveland Clinic的执行董事，这是e-health临床项目在互联网上提供的一个系列。Harris 博士是HealthStream Inc. NASDAQ, Nashville, Tennessee的董事，该公司为在美国的医疗行业提供基于互联网的培训，信息，和教育的学习和研究解决方案；并且是位于马萨诸塞州，沃尔瑟姆的Thermo Fisher Scientific Inc. （NYSE）（纽约证券交易所）的董事，该公司为研究、制造、分析，发现和诊断提供分析仪器、设备、试剂和耗材，软件和服务。Harris 博士是Sentillion Corporation的董事，一个位于马萨诸塞州安多弗的医疗软件科技公司，在2010年初被卖给微软公司（Microsoft Corporation）。
- C. Martin Harris,has served as Vice President of the Health Enterprise and Chief Business Officer of the Dell Medical School at The University of Texas at Austin since 2016. Dr. Harris previously served as Chief Information Officer and Chairman of the Information Technology Division of The Cleveland Clinic Foundation, a non-profit academic medical center, and a Staff Physician for The Cleveland Clinic Hospital and The Cleveland Clinic Foundation Department of General Internal Medicine from 1996 to 2016. Additionally, from 2000 to 2016, he was Executive Director of e-Cleveland Clinic, a series of e-health clinical programs offered over the internet. Prior to joining the Cleveland Clinic, Dr. Harris spent 14 years with the School of Medicine at the University of Pennsylvania.
- Baiju R. Shah
-
自2011年起，Baiju R. Shah一直任董事。自2012年8月以来任BioMotiv董事兼首席执行官。BioMotiv是一家专注于推进发现从研究机构到新药品的投资组合公司。在此之前，从2004年至2012年8月他曾任BioEnterprise Cleveland 总裁兼首席执行官，从2003年2012年任高级副总裁，从2002年到2003年任副总裁。BioEnterprise是总部位于 Cleveland的企业结构，招聘和加速倡议，旨在壮大医疗保健公司和商业化生物医学技术。加入BioEnterprise前，他就职于 McKinsey & Company，在那里他是在其成长和商务大厦实践的领导者。此外，他担任 Dual Therapeutics, LLC，该公司专注于生产癌症治疗和Orca Pharmaceuticals, LLC，这是一家药品开发商的董事。他还参加几个民间，非营利和顾问委员会委员，包括 RBS Citizens/Charter One。
Baiju R. Shah has been a director since 2011. Mr. Shah has been the CEO and a director of BioMotiv since August 2012. BioMotiv is a company focused on developing a portfolio of drug discoveries from research institutions into new medicines. Prior to that, Mr. Shah was President and CEO of BioEnterprise Cleveland from 2004 to August 2012 Senior Vice President from 2003 to 2004 and a Vice President from 2002 to 2003. BioEnterprise is a Cleveland-based business formation, recruitment and acceleration initiative designed to grow health care companies and commercialize biomedical technologies. Prior to BioEnterprise, Mr. Shah worked for McKinsey & Company, where he was a leader in its Growth and Business Building practice. In addition to BioMotiv, Mr. Shah serves as a director of several privately held biomedical-related companies, on the advisory board of Citizens Financial Group NYSE: CFG and on several civic non-profit boards. - 自2011年起，Baiju R. Shah一直任董事。自2012年8月以来任BioMotiv董事兼首席执行官。BioMotiv是一家专注于推进发现从研究机构到新药品的投资组合公司。在此之前，从2004年至2012年8月他曾任BioEnterprise Cleveland 总裁兼首席执行官，从2003年2012年任高级副总裁，从2002年到2003年任副总裁。BioEnterprise是总部位于 Cleveland的企业结构，招聘和加速倡议，旨在壮大医疗保健公司和商业化生物医学技术。加入BioEnterprise前，他就职于 McKinsey & Company，在那里他是在其成长和商务大厦实践的领导者。此外，他担任 Dual Therapeutics, LLC，该公司专注于生产癌症治疗和Orca Pharmaceuticals, LLC，这是一家药品开发商的董事。他还参加几个民间，非营利和顾问委员会委员，包括 RBS Citizens/Charter One。
- Baiju R. Shah has been a director since 2011. Mr. Shah has been the CEO and a director of BioMotiv since August 2012. BioMotiv is a company focused on developing a portfolio of drug discoveries from research institutions into new medicines. Prior to that, Mr. Shah was President and CEO of BioEnterprise Cleveland from 2004 to August 2012 Senior Vice President from 2003 to 2004 and a Vice President from 2002 to 2003. BioEnterprise is a Cleveland-based business formation, recruitment and acceleration initiative designed to grow health care companies and commercialize biomedical technologies. Prior to BioEnterprise, Mr. Shah worked for McKinsey & Company, where he was a leader in its Growth and Business Building practice. In addition to BioMotiv, Mr. Shah serves as a director of several privately held biomedical-related companies, on the advisory board of Citizens Financial Group NYSE: CFG and on several civic non-profit boards.
高管简历
中英对照 | 中文 | 英文- Matthew E. Monaghan
Matthew E. Monaghan，他于2015年4月1日被正式任命为公司的总裁兼首席执行官。2014年1月以来，他曾一直担任Zimmer Holdings, Inc.（NYSE：ZMH）的高级副总裁，负责全球高完整性保护系统和复原研究。Zimmer Holdings公司设计、开发、制造和营销整形重建、脊椎和创伤设备、牙科植入物，以及相关外科产品。他曾领导公司的全球高完整性保护系统业务和大型联合复原研究，在那里他负责部门的新产品开发、工程、市场营销、临床研究、质量、法规事务、共享销售结果和供应链职能。从2009年12月到2014年1月，他担任Zimmer公司的副总裁兼总经理，负责全球高完整性保护系统业务。2009年加入Zimmer公司之前，他曾任职两个领先私人股本公司（Texas Pacific Group （TPG） 、Cerberus Capital Management）8年，担任运营执行官，在那里他曾领导投资公司的收购和业务改进（包括Baxter Healthcare的全球医疗设备业务分离，以及美国个人保险业务的显著改善，并运营一个Newell-Rubbermaid公司拆分出来的耐用消费品业务）。任职Cerberus Capital公司期间，他曾担任Global Home Products公司（Cerberus公司的一个耐用消费品业务）的首席运营官（从2004年4月到2005年11月）。Global Home Products公司于2006年4月根据美国破产法第11章提出自愿重组的请愿书。Global Home Products公司于2008年2月摆脱破产。13年以上，他曾担任General Electric （NYSE：GE）的多种职务（2003年之前）。
Matthew E. Monaghan,President and Chief Executive Officer at Invacare Corporation NYSE:IVC, a medical device manufacturer for the home and long-term healthcare markets since 2015.Senior Vice President and General Manager, Global Hips and Reconstructive Research for Zimmer Biomet Holdings, Inc. formerly known as Zimmer Holdings, Inc. (NYSE:ZBH), a global company that designs, develops, manufactures and markets orthopedic reconstructive, spinal and trauma devices, dental implants, and related surgical products (2014-2015).Operating Executive for Texas Pacific Group (2006 to 2009).Cerberus Capital Management (2003 to 2005).13 years in the aerospace, medical and other industrial businesses of General Electric.- Matthew E. Monaghan，他于2015年4月1日被正式任命为公司的总裁兼首席执行官。2014年1月以来，他曾一直担任Zimmer Holdings, Inc.（NYSE：ZMH）的高级副总裁，负责全球高完整性保护系统和复原研究。Zimmer Holdings公司设计、开发、制造和营销整形重建、脊椎和创伤设备、牙科植入物，以及相关外科产品。他曾领导公司的全球高完整性保护系统业务和大型联合复原研究，在那里他负责部门的新产品开发、工程、市场营销、临床研究、质量、法规事务、共享销售结果和供应链职能。从2009年12月到2014年1月，他担任Zimmer公司的副总裁兼总经理，负责全球高完整性保护系统业务。2009年加入Zimmer公司之前，他曾任职两个领先私人股本公司（Texas Pacific Group （TPG） 、Cerberus Capital Management）8年，担任运营执行官，在那里他曾领导投资公司的收购和业务改进（包括Baxter Healthcare的全球医疗设备业务分离，以及美国个人保险业务的显著改善，并运营一个Newell-Rubbermaid公司拆分出来的耐用消费品业务）。任职Cerberus Capital公司期间，他曾担任Global Home Products公司（Cerberus公司的一个耐用消费品业务）的首席运营官（从2004年4月到2005年11月）。Global Home Products公司于2006年4月根据美国破产法第11章提出自愿重组的请愿书。Global Home Products公司于2008年2月摆脱破产。13年以上，他曾担任General Electric （NYSE：GE）的多种职务（2003年之前）。
- Matthew E. Monaghan,President and Chief Executive Officer at Invacare Corporation NYSE:IVC, a medical device manufacturer for the home and long-term healthcare markets since 2015.Senior Vice President and General Manager, Global Hips and Reconstructive Research for Zimmer Biomet Holdings, Inc. formerly known as Zimmer Holdings, Inc. (NYSE:ZBH), a global company that designs, develops, manufactures and markets orthopedic reconstructive, spinal and trauma devices, dental implants, and related surgical products (2014-2015).Operating Executive for Texas Pacific Group (2006 to 2009).Cerberus Capital Management (2003 to 2005).13 years in the aerospace, medical and other industrial businesses of General Electric.
- Kathleen P. Leneghan
KathleenP.Leneghan于2018年2月被任命为Invacare Corporation高级副总裁兼首席财务官，此前自2017年11月起担任该公司临时首席财务官。她自2003年以来担任该公司的Vice President和财务总监。Leneghan女士受聘于该公司28年，在北美和欧洲担任各种财务角色。在加入公司之前，Leneghan女士是Ernst&Young LLP的审计经理。
Kathleen P. Leneghan was appointed as the Senior Vice President and Chief Financial Officer of Invacare Corporation in February 2018 after serving as interim Chief Financial Officer of the company since November 2017. She served as Vice President and Corporate Controller of the company since 2003. Ms. Leneghan has been employed by the company for 28 years, serving in various financial roles in North America and Europe. Prior to joining the company, Ms. Leneghan was an audit manager with Ernst & Young LLP.- KathleenP.Leneghan于2018年2月被任命为Invacare Corporation高级副总裁兼首席财务官，此前自2017年11月起担任该公司临时首席财务官。她自2003年以来担任该公司的Vice President和财务总监。Leneghan女士受聘于该公司28年，在北美和欧洲担任各种财务角色。在加入公司之前，Leneghan女士是Ernst&Young LLP的审计经理。
- Kathleen P. Leneghan was appointed as the Senior Vice President and Chief Financial Officer of Invacare Corporation in February 2018 after serving as interim Chief Financial Officer of the company since November 2017. She served as Vice President and Corporate Controller of the company since 2003. Ms. Leneghan has been employed by the company for 28 years, serving in various financial roles in North America and Europe. Prior to joining the company, Ms. Leneghan was an audit manager with Ernst & Young LLP.
- Ralf A. Ledda
RalfA.Ledda于2016年11月被任命为欧洲、中东和非洲高级副总裁兼总经理。此前，他担任Alber GmbH，Albstadt，Germany，Invacare&8217；的子公司的董事总经理21年，该公司专门从事创新的电动技术和用于医疗和娱乐产品的电源附加设备。
Ralf A. Ledda was appointed Senior Vice President and General Manager, Europe, Middle East & Africa in November 2016. Previously he served for 21 years as Managing Director of Alber GmbH, Albstadt, Germany, Invacare’s subsidiary that specializes in innovative electromotive technology and power add-on devices used with medical and recreational products.- RalfA.Ledda于2016年11月被任命为欧洲、中东和非洲高级副总裁兼总经理。此前，他担任Alber GmbH，Albstadt，Germany，Invacare&8217；的子公司的董事总经理21年，该公司专门从事创新的电动技术和用于医疗和娱乐产品的电源附加设备。
- Ralf A. Ledda was appointed Senior Vice President and General Manager, Europe, Middle East & Africa in November 2016. Previously he served for 21 years as Managing Director of Alber GmbH, Albstadt, Germany, Invacare’s subsidiary that specializes in innovative electromotive technology and power add-on devices used with medical and recreational products.
- Darcie L. Karol
DarcieL.Karol于2018年6月被任命为高级副总裁，人力资源。在加入公司之前，卡罗尔女士曾在The Valspar Corporation工作，该公司是一家全球性涂料公司，于2017年6月被宣威威廉姆斯收购。卡罗尔女士于2014年1月至2017年8月担任Valspar&；8217；全球涂料人力资源Vice President，在此之前，于2011年7月至2013年9月担任Valspar&；8217；亚洲区人力资源总监。任职Valspar公司之前，Karol女士曾在通用磨坊公司公司（一家全球消费品包装公司）担任越来越重要的人力资源职务。
Darcie L. Karol was appointed Senior Vice President, Human Resources in June 2018. Prior to joining the company, Ms. Karol worked at the Valspar Corporation, a global paint and coatings company acquired by Sherwin-Williams in June 2017. Ms. Karol served as Valspar’s Vice President of Human Resources - Global Coatings from January 2014 until August 2017 and prior to that was Valspar’s Human Resources Director for the Asia Region from July 2011 until September 2013. Prior to Valspar, Ms. Karol held Human Resources roles of increasing responsibility at General Mills, Inc., a global consumer packaged goods company.- DarcieL.Karol于2018年6月被任命为高级副总裁，人力资源。在加入公司之前，卡罗尔女士曾在The Valspar Corporation工作，该公司是一家全球性涂料公司，于2017年6月被宣威威廉姆斯收购。卡罗尔女士于2014年1月至2017年8月担任Valspar&；8217；全球涂料人力资源Vice President，在此之前，于2011年7月至2013年9月担任Valspar&；8217；亚洲区人力资源总监。任职Valspar公司之前，Karol女士曾在通用磨坊公司公司（一家全球消费品包装公司）担任越来越重要的人力资源职务。
- Darcie L. Karol was appointed Senior Vice President, Human Resources in June 2018. Prior to joining the company, Ms. Karol worked at the Valspar Corporation, a global paint and coatings company acquired by Sherwin-Williams in June 2017. Ms. Karol served as Valspar’s Vice President of Human Resources - Global Coatings from January 2014 until August 2017 and prior to that was Valspar’s Human Resources Director for the Asia Region from July 2011 until September 2013. Prior to Valspar, Ms. Karol held Human Resources roles of increasing responsibility at General Mills, Inc., a global consumer packaged goods company.
- Anthony C. LaPlaca
Anthony C. LaPlaca 被任命为高级副总裁，总法律顾问兼秘书并于2009年1月生效。他曾担任Bendix Commercial Vehicle Systems LLC副总裁兼总顾问有6年半的时间，该公司是 Knorr-Bremse group的成员，也是商用车安全系统供应商。 在此之前，他担任Honeywell Transportation & Power Systems 副总裁兼总法律顾问和Honeywell Commercial Vehicle Systems LLC总法律顾问。
Anthony C. LaPlaca was appointed Senior Vice President, General Counsel and Secretary effective January 2009. Previously, Mr. LaPlaca served as Vice President and General Counsel for six and a half years with Bendix Commercial Vehicle Systems LLC, Elyria, Ohio, a member of the Knorr-Bremse group, a supplier of commercial vehicle safety systems. Prior to that, he served as Vice President and General Counsel to Honeywell Transportation & Power Systems and General Counsel to Honeywell Commercial Vehicle Systems LLC.- Anthony C. LaPlaca 被任命为高级副总裁，总法律顾问兼秘书并于2009年1月生效。他曾担任Bendix Commercial Vehicle Systems LLC副总裁兼总顾问有6年半的时间，该公司是 Knorr-Bremse group的成员，也是商用车安全系统供应商。 在此之前，他担任Honeywell Transportation & Power Systems 副总裁兼总法律顾问和Honeywell Commercial Vehicle Systems LLC总法律顾问。
- Anthony C. LaPlaca was appointed Senior Vice President, General Counsel and Secretary effective January 2009. Previously, Mr. LaPlaca served as Vice President and General Counsel for six and a half years with Bendix Commercial Vehicle Systems LLC, Elyria, Ohio, a member of the Knorr-Bremse group, a supplier of commercial vehicle safety systems. Prior to that, he served as Vice President and General Counsel to Honeywell Transportation & Power Systems and General Counsel to Honeywell Commercial Vehicle Systems LLC.